Inflammatory 'double hit' model of temporomandibular joint disorder with elevated CCL2, CXCL9, CXCL10, RANTES and behavioural hypersensitivity in TNFR1/R2-/- mice

被引:15
|
作者
McIlwrath, S. L. [1 ]
Nesemeier, R. [1 ]
Ma, F. [1 ]
Oz, H. S. [1 ]
Zhang, L. [1 ]
Westlund, K. N. [1 ]
机构
[1] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40506 USA
关键词
TUMOR-NECROSIS-FACTOR; INTERLEUKIN-1 RECEPTOR ANTAGONIST; NORMAL INTESTINAL MICROBIOTA; EARLY RHEUMATOID-ARTHRITIS; SYNOVIAL-FLUID; FACTOR-ALPHA; TNF-ALPHA; PROINFLAMMATORY CYTOKINES; NEUROPATHIC PAIN; SPINAL-CORD;
D O I
10.1002/ejp.1021
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Patients with temporomandibular joint disorders (TMD), reactive arthritis and rheumatoid arthritis often have combined etiology of hereditary and microenvironmental factors contributing to joint pain. Multiple clinical and animal studies indicate `double-hit' inflammatory insults can cause chronic inflammation. The first inflammatory insult primes the immune system and subsequent insults elicit amplified responses. The present `double hit' study produced a chronic orofacial pain model in mice with genetic deletion of both TNFa receptors (TNFR1/R2-/-), investigating the main nociceptive signalling pathways in comparisons to wild type mice. Methods: An initial inflammatory insult was given unilaterally into the temporomandibular joint (TMJ). Secondary hypersensitivity was tested on the skin over the TMJ throughout the experiment. Three weeks later after complete reversal of hypersensitivity, a second inflammatory insult was imposed on the colon. Pharmacological interventions were tested for efficacy after week 10 when hypersensitivity was chronic in TNFR1/R2-/- mice. Serum cytokines were analysed at Days 1, 14, and Week 18. Results: The double hit insult produced chronic hypersensitivity continuing through the 4-month experimental timeline in the absence of TNFa signalling. P2X7 and NMDA receptor antagonists temporarily attenuated chronic hypersensitivity. Serum cytokine/chemokine analysis on Day 14 when CFA induced hypersensitivity was resolved identified increased levels of pro-inflammatory cytokines CCL2, CXCL9, CXCL10, RANTES and decreased levels of anti-inflammatory cytokines IL-1ra and IL-4 in TNFR1/R2-/- compared to WT mice. Conclusions: These data suggest a causal feed-forward signalling cascade of these little studied cytokines have the potential to cause recrudescence in this orofacial inflammatory pain model in the absence of TNFa signalling. Significance: Using a mouse model of chronic inflammatory temporomandibular joint disorder, we determined that absence of functional TNFR1/R2 induces aberrant inflammatory signalling caused by other increased pro-inflammatory and decreased anti-inflammatory cytokines that could serve as blood biomarkers and may predict disease progression.
引用
收藏
页码:1209 / 1223
页数:15
相关论文
共 11 条
  • [1] Autocrine CCL2, CXCL4, CXCL9 and CXCL10 signal in retinal endothelial cells and are enhanced in diabetic retinopathy
    Nawaz, M. I.
    Van Raemdonck, K.
    Mohammad, G.
    Kangave, D.
    Van Damme, J.
    Abu El-Asrar, A. M.
    Struyf, S.
    EXPERIMENTAL EYE RESEARCH, 2013, 109 : 67 - 76
  • [2] Equine herpesvirus type-1 modulates CCL2, CCL3, CCL5, CXCL9, and CXCL10 chemokine expression
    Wimer, Christine L.
    Damiani, Armando
    Osterrieder, Nikolaus
    Wagner, Bettina
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2011, 140 (3-4) : 266 - 274
  • [3] CCL2, CXCL8, CXCL9 and CXCL10 serum levels increase with age but are not altered by treatment with hydroxychloroquine in patients with osteoarthritis of the knees
    Bonfante, Herval de Lacerda
    Almeida, Caroline de Souza
    Abramo, Clarice
    Ferraz Grunewald, Sabrine Teixeira
    Levy, Roger Abramino
    Teixeira, Henrique Couto
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (12) : 1958 - 1964
  • [4] Intermittent hypoxia-specific expression of CCL2, CXCL9, and CXCL10 genes via NFkappaB activation in pancreatic beta cells
    Ota, H.
    Tamaki, S.
    Itaya-Hironaka, A.
    Yamauchi, A.
    Sakuramoto-Tsuchida, S.
    Morioka, T.
    Dohi, Y.
    Takasawa, S.
    Kimura, H.
    DIABETOLOGIA, 2009, 52 : S157 - S157
  • [5] Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic
    Baresi, Giulia
    Giacomelli, Mauro
    Moratto, Daniele
    Chiarini, Marco
    Conforti, Immacolata Claudia
    Padoan, Rita
    Poli, Piercarlo
    Timpano, Silviana
    Caldarale, Francesca
    Badolato, Raffaele
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [6] Tumor treating fields enhance anti-PD therapy by improving CCL2/8 and CXCL9/CXCL10 expression through inducing immunogenic cell death in NSCLC models
    Lin, Wei
    Wang, Yingying
    Li, Minghao
    Feng, Jingjing
    Yue, Ying
    Yu, Jing
    Hu, Yanjiang
    Suo, Yuanzhen
    BMC CANCER, 2025, 25 (01)
  • [7] Production and in vivo effects of chemokines CXCL1-3/KC and CCL2/JE in a model of inflammatory angiogenesis in mice
    L. S. Barcelos
    A. Talvani
    A. S. Teixeira
    G. D. Cassali
    S. P. Andrade
    M. M. Teixeira
    Inflammation Research, 2004, 53 : 576 - 584
  • [8] Production and in vivo effects of chemokines CXCL1-3/KC and CCL2/JE in a model of inflammatory angiogenesis in mice
    Barcelos, LS
    Talvani, A
    Teixeira, AS
    Cassali, GD
    Andrade, SP
    Teixeira, MM
    INFLAMMATION RESEARCH, 2004, 53 (10) : 576 - 584
  • [9] Reduced 2,4-dinitro-1-fluorobenzene-induced contact hypersensitivity response in IL-15 receptor α-deficient mice correlates with diminished CCL5/RANTES and CXCL10/IP-10 expression
    Chen, JP
    Liao, NS
    Lai, SL
    Hsu, L
    Mao, WY
    Ku, MC
    Liao, F
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (03) : 690 - 698
  • [10] Calcitonin gene-related peptide (CGRP) induces production of the TH2 chemokines CCL17 and CCL22 but inhibits the stimulated production of the TH1 chemokines CXCL9 and CXCL10 by Langerhans cells (LCs)
    Ding, W.
    Stohl, L.
    Zapolanski, T.
    Kakimi, A.
    Granstein, R. D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S112 - S112